尼日利亚恶性疟原虫分离株Pfatpase-6基因的分子谱分析

Deborah Adedire, Chiamaka Iwegbulam, Roland Funwei, Temitope Owoeye, Zainab Kashim-Bello, Adeola Orogade, Catherine Falade, Oyekanmi Nash
{"title":"尼日利亚恶性疟原虫分离株Pfatpase-6基因的分子谱分析","authors":"Deborah Adedire, Chiamaka Iwegbulam, Roland Funwei, Temitope Owoeye, Zainab Kashim-Bello, Adeola Orogade, Catherine Falade, Oyekanmi Nash","doi":"10.53771/ijlsra.2023.4.1.0153","DOIUrl":null,"url":null,"abstract":"Anti-malarial drug resistance is one of the biggest public health burdens confronting global malaria control programmes. The emergence of P. falciparum chloroquine resistance transporter and multi-drug resistance mutant genes had devastating effects on the therapeutic efficacy of chloroquine when it was the drug of choice for malaria treatment. The artemisinins have proven to be an excellent therapeutic alternative to fill the void in chemotherapeutic options left by resistance mechanisms. The sarco/endoplasmic reticulum Ca2+-ATPase ortholog of P. falciparum (PfATPase-6) has been suggested as one of the targets of the artemisinins. Consequently, Pfatpase-6 gene polymorphisms are being investigated as markers of artemisinin resistance elsewhere. The present study assessed the molecular profile of the current prevalence of four P. falciparum candidate artemisinin resistance biomarkers L263E, E431K, A623E, and S769N in the Pfatpase-6 gene in 113 samples of P. falciparum isolates collected from Ibadan, Oyo State, Nigeria between 2017 and 2018. The frequency of occurrence of E431K mutation was 17% from collected samples. No A623E, L263E and S769N were detected. The result suggests that resistance to artemisinin has either not yet been selected in Nigeria or other genes mutations might be responsible for such, if at all","PeriodicalId":14144,"journal":{"name":"International Journal of Life Science Research Archive","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular profile of Pfatpase-6 gene from Plasmodium falciparum isolates in Nigeria\",\"authors\":\"Deborah Adedire, Chiamaka Iwegbulam, Roland Funwei, Temitope Owoeye, Zainab Kashim-Bello, Adeola Orogade, Catherine Falade, Oyekanmi Nash\",\"doi\":\"10.53771/ijlsra.2023.4.1.0153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Anti-malarial drug resistance is one of the biggest public health burdens confronting global malaria control programmes. The emergence of P. falciparum chloroquine resistance transporter and multi-drug resistance mutant genes had devastating effects on the therapeutic efficacy of chloroquine when it was the drug of choice for malaria treatment. The artemisinins have proven to be an excellent therapeutic alternative to fill the void in chemotherapeutic options left by resistance mechanisms. The sarco/endoplasmic reticulum Ca2+-ATPase ortholog of P. falciparum (PfATPase-6) has been suggested as one of the targets of the artemisinins. Consequently, Pfatpase-6 gene polymorphisms are being investigated as markers of artemisinin resistance elsewhere. The present study assessed the molecular profile of the current prevalence of four P. falciparum candidate artemisinin resistance biomarkers L263E, E431K, A623E, and S769N in the Pfatpase-6 gene in 113 samples of P. falciparum isolates collected from Ibadan, Oyo State, Nigeria between 2017 and 2018. The frequency of occurrence of E431K mutation was 17% from collected samples. No A623E, L263E and S769N were detected. The result suggests that resistance to artemisinin has either not yet been selected in Nigeria or other genes mutations might be responsible for such, if at all\",\"PeriodicalId\":14144,\"journal\":{\"name\":\"International Journal of Life Science Research Archive\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Life Science Research Archive\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53771/ijlsra.2023.4.1.0153\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Life Science Research Archive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53771/ijlsra.2023.4.1.0153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

抗疟疾药物耐药性是全球疟疾控制规划面临的最大公共卫生负担之一。当氯喹作为治疗疟疾的首选药物时,恶性疟原虫氯喹耐药转运体和多药耐药突变基因的出现对氯喹的治疗效果产生了破坏性影响。青蒿素已被证明是填补耐药机制留下的化疗方案空白的一种极好的治疗选择。恶性疟原虫的sarco/内质网Ca2+- atp酶同源物(PfATPase-6)被认为是青蒿素的靶点之一。因此,正在其他地方研究Pfatpase-6基因多态性作为青蒿素耐药性的标记。本研究评估了2017年至2018年在尼日利亚奥约州伊巴丹收集的113份恶性疟原虫分离物样本中Pfatpase-6基因中4种恶性疟原虫候选青蒿素耐药生物标志物L263E、E431K、A623E和S769N的当前流行情况。E431K突变发生率为17%。未检出A623E、L263E和S769N。这一结果表明,在尼日利亚,对青蒿素的耐药性要么尚未被选择,要么可能是其他基因突变导致的,如果有的话
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular profile of Pfatpase-6 gene from Plasmodium falciparum isolates in Nigeria
Anti-malarial drug resistance is one of the biggest public health burdens confronting global malaria control programmes. The emergence of P. falciparum chloroquine resistance transporter and multi-drug resistance mutant genes had devastating effects on the therapeutic efficacy of chloroquine when it was the drug of choice for malaria treatment. The artemisinins have proven to be an excellent therapeutic alternative to fill the void in chemotherapeutic options left by resistance mechanisms. The sarco/endoplasmic reticulum Ca2+-ATPase ortholog of P. falciparum (PfATPase-6) has been suggested as one of the targets of the artemisinins. Consequently, Pfatpase-6 gene polymorphisms are being investigated as markers of artemisinin resistance elsewhere. The present study assessed the molecular profile of the current prevalence of four P. falciparum candidate artemisinin resistance biomarkers L263E, E431K, A623E, and S769N in the Pfatpase-6 gene in 113 samples of P. falciparum isolates collected from Ibadan, Oyo State, Nigeria between 2017 and 2018. The frequency of occurrence of E431K mutation was 17% from collected samples. No A623E, L263E and S769N were detected. The result suggests that resistance to artemisinin has either not yet been selected in Nigeria or other genes mutations might be responsible for such, if at all
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信